, ,
Presentations this author is a contributor to:
Comparison of vildagliptin with placebo in a 24-week study of 221 patients with type 2 diabetes and severe renal impairment (eGFR<30) (#303)
1:30 PM
Joseph Proietto
ADS Clinical Poster Session
The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model (#264)
1:30 PM
Anthony E Dear
ADS Clinical Poster Session